STARTUP PROFILE

Fisher Wallace Labs

COUNTRY
USA
FOUNDED
2007
CATEGORY
Neuromodulation
Offering an FDA-cleared cranial electrotherapy stimulator that non-invasively treats depression, anxiety, and insomnia via home use.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Fisher Wallace Labs is a long-standing player in cranial electrotherapy stimulation, offering home-use devices for depression and anxiety. Its regulatory pathway and consumer accessibility drive adoption, though clinical efficacy debates persist.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Fisher Wallace Labs
No items found.